Bimatoprost

Overview

Bimatoprost is a prostaglandin analog used to treat certain types of glaucoma and ocular hypertension by reducing intraocular pressure. It also has cosmetic uses for promoting eyelash growth in individuals with hypotrichosis or inadequate eyelashes.

API suppliers (10)

Suppliers of Bimatoprost backed by a verifiable FDA Type II Drug Master File. Source: FDA quarterly DMF list.

• YS LIFE SCIENCE CO LTD1 active DMF
• SCINOPHARM TAIWAN LTD1 active DMF
• CHIROGATE INTERNATIONAL INCTaiwan1 active DMF
• EVERLIGHT CHEMICAL INDUSTRIAL CORPTaiwan1 active DMF
• CHIROGATE INTERNATIONAL INCTaiwan1 active DMF
• EVERLIGHT CHEMICAL INDUSTRIAL CORPTaiwan1 active DMF
• INDUSTRIALE CHIMICA SRLItaly1 active DMF
• CAYMAN PHARMA SRO1 active DMF
• YS LIFE SCIENCE CO LTD1 active DMF
• Lupin LimitedIndia

Patent & exclusivity (US)

Per the FDA Orange Book (15 approved US products), the latest listed US patent on Bimatoprost expires 7 Jun 2036 and exclusivity 8 Sept 2028. Generic API sourcing typically opens up once these lapse.

Therapeutic areas